175 results on '"Sollima, Salvatore"'
Search Results
2. Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
3. Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV/HIV coinfected patients
4. Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
5. Gastrointestinal basidiobolomycosis: An emerging mycosis difficult to diagnose but curable. Case report and review of the literature
6. Prise en charge de l’infection par le virus de l’hépatite B chez les patients atteints de polyarthrite rhumatoïde : conférence de consensus italienne
7. Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis
8. Candidemia and invasive candidiasis in adults: A narrative review
9. Darunavir-based Antiretroviral Therapy may Affect the Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in HCV/HIV-1 Coinfected Patients
10. HCV-Negative Mixed Cryoglobulinemia: Facts and Fancies
11. HBV/HCV Co-infection and Mixed Cryoglobulinemia
12. Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study
13. Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases
14. Short article: Retreatment of chronic hepatitis C virus infection after unsuccessful therapy with all-oral direct-acting antiviral regimens: a real-life experience
15. Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient
16. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients
17. Renal function in HIV/HBV co‐infected and HBV mono‐infected patients on a long‐term treatment with tenofovir in real life setting
18. Fungal Endocarditis Observed Over an 8-Year Period and a Review of the Literature
19. Reduced raltegravir clearance in HIV-infected liver transplant recipients: an unexpected interaction with immunosuppressive therapy?
20. Paritaprevir/ritonavir, ombitasvir, and dasabuvir for treatment of recurrent hepatitis C virus infection in the human immunodeficiency virus coinfected liver transplant recipient
21. SARS-COV-2 infection: Across the border into the family
22. Darunavir does not prevent SARS-CoV-2 infection in HIV patients
23. Cryoglobulinaemic Vasculitis
24. HBV/HCV Co-infection and Mixed Cryoglobulinemia
25. HCV-Negative Mixed Cryoglobulinemia: Facts and Fancies
26. Outcome of a second-line protease inhibitor-containing regimen in patients failing or intolerant of a first highly active antiretroviral therapy
27. Disseminated Penicillium marneffei Infection in an HIV-Positive Italian Patient and a Review of Cases Reported Outside Endemic Regions
28. Sarcoidosis Presenting with Massive Involvement of the Nervous System
29. Histoplasmosis among human immunodeficiency virus-infected people in Europe report of 4 cases and review of the literature
30. Immunovirological outcomes in 70 HIV-1-infected patients who switched to lopinavir/ritonavir after failing at least one protease inhibitor-containing regimen: a retrospective cohort study
31. Severe imported falciparum malaria. Dilemmas regarding treatment availability and tolerability
32. Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin
33. Protease inhibitors and erectile dysfunction
34. CD4 cell counts at the third month of HAART may predict clinical failure
35. THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME
36. THU-122-Sofosbuvir/velpatasvir ± ribavirin for retreatment of patients with chronic hepatitis C virus infection and advanced fibrosis failing to a previous DAA combination regimen
37. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection
38. Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis
39. Epidemiological trends of infective endocarditis in a single center in Italy between 2003–2015
40. Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients
41. Short article
42. Direct-Acting Antivirals and Mixed Cryoglobulinemia Vasculitis: Long-Term Outcome of Patients Achieving HCV Eradication
43. Critically ill patients at risk of invasive candidiasis: The “dilemma” of the best antifungal treatment strategy
44. Evolution of Resistance-Associated Variants of All-Oral Direct-Acting Antiviral Therapy of Hepatitis C in a Clinical Setting
45. Successful treatment of sexually acquired acute HCV reinfection with ledipasvir/sofosbuvir in a HIV-infected patient
46. South Sudan to Martha's Vineyard: Malaria Always First!
47. Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy: Table 1
48. Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient
49. A comparison between entecavir and tenofovir in chronic hepatitis B in the clinical practice: a single-center experience
50. Renal function in HIV/ HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.